0.0438
price down icon17.98%   -0.0096
 
loading
Precedente Chiudi:
$0.0534
Aprire:
$0.0516
Volume 24 ore:
112.45M
Relative Volume:
4.10
Capitalizzazione di mercato:
$2.48M
Reddito:
-
Utile/perdita netta:
$-33.44M
Rapporto P/E:
-0.00273
EPS:
-16.0242
Flusso di cassa netto:
$-28.30M
1 W Prestazione:
+4.29%
1M Prestazione:
-95.17%
6M Prestazione:
-97.06%
1 anno Prestazione:
-98.81%
Intervallo 1D:
Value
$0.0429
$0.055
Intervallo di 1 settimana:
Value
$0.0325
$0.0671
Portata 52W:
Value
$0.0325
$10.79

Nucana Plc Adr Stock (NCNA) Company Profile

Name
Nome
Nucana Plc Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
22
Name
Cinguettio
@NuCana_news
Name
Prossima data di guadagno
2024-11-14
Name
Ultimi documenti SEC
Name
NCNA's Discussions on Twitter

Confronta NCNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NCNA
Nucana Plc Adr
0.0438 254.39K 0 -33.44M -28.30M -16.02
Biotechnology icon
ONC
Beigene Ltd Adr
228.38 25.07B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.65 109.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.27 36.39M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
594.32 56.98B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
71.31 5.39B 0 -153.72M -103.81M -2.00

Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-30 Downgrade William Blair Outperform → Mkt Perform
2022-03-03 Downgrade Cowen Outperform → Market Perform
2020-10-22 Iniziato Truist Buy
2020-07-24 Iniziato Oppenheimer Outperform
2019-08-19 Iniziato H.C. Wainwright Buy
2018-10-19 Iniziato Piper Jaffray Overweight
2017-10-23 Iniziato Citigroup Buy
2017-10-23 Iniziato Jefferies Buy
2017-10-23 Iniziato William Blair Outperform
Mostra tutto

Nucana Plc Adr Borsa (NCNA) Ultime notizie

pulisher
May 08, 2025

Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga

May 08, 2025
pulisher
May 06, 2025

NuCana prices $7 million direct offering of ADSs and warrants - Investing.com

May 06, 2025
pulisher
May 06, 2025

NuCana prices $7 million direct offering of ADSs and warrants By Investing.com - Investing.com India

May 06, 2025
pulisher
May 03, 2025

New Outlook On NuCana plc ADR - Stocksregister

May 03, 2025
pulisher
Apr 25, 2025

NCNA’s Stock Journey: What Investors Need to Know About NuCana plc ADR’s Performance - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Do investors need to be concerned about Cadiz Inc (CDZI)? - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Natera Inc (NTRA) deserves closer scrutiny - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Weave Communications Inc (WEAV) produces promising results - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Investing in NuCana plc ADR (NCNA) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

Post-Trade Analysis: NuCana plc ADR (NCNA) Slides -26.97, Closing at 0.65 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Closing Bell Recap: Yxt.Com Group Holding Ltd. ADR (YXT) Ends at 0.56, Reflecting a -14.42 Downturn - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

In the Green: Gogoro Inc (GGR) Closes at 0.26, Up/Down 0.08 from Previous Day - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Daily Market Movement: Tivic Health Systems Inc (TIVC) Sees a 1.88 Increase, Closing at 7.04 - DWinneX

Apr 25, 2025
pulisher
Apr 09, 2025

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Barchart.com

Apr 09, 2025
pulisher
Mar 12, 2025

Stock Update - Investorsobserver

Mar 12, 2025
pulisher
Nov 25, 2024

NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan

Nov 25, 2024
pulisher
Sep 17, 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance

Sep 17, 2024
pulisher
Sep 03, 2024

Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials - Investing.com

Sep 03, 2024
pulisher
Aug 29, 2024

NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks

Aug 29, 2024
pulisher
Jul 22, 2024

NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com

Jul 22, 2024
pulisher
Mar 27, 2024

NuCana plc Announces Reverse ADS Split - TipRanks

Mar 27, 2024
pulisher
Jan 03, 2024

NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha

Jan 03, 2024
pulisher
Oct 05, 2022

Here's Why NuCana PLC Sponsored ADR (NCNA) is Poised for a Turnaround After Losing 26.5% in 4 Weeks - Yahoo Finance

Oct 05, 2022
pulisher
Mar 04, 2022

Down 57.3% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Nasdaq

Mar 04, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Jan 11, 2021

NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session - Yahoo Finance

Jan 11, 2021
pulisher
Jun 01, 2020

Will NuCana Continue to Surge Higher? - Nasdaq

Jun 01, 2020
pulisher
Sep 29, 2017

NCNA Stock Price and Chart — NASDAQ:NCNA - TradingView

Sep 29, 2017
pulisher
Sep 24, 2017

NuCana PLC Stock Price Today | NASDAQ: NCNA Live - Investing.com

Sep 24, 2017

Nucana Plc Adr Azioni (NCNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.28
price down icon 1.54%
$30.93
price up icon 7.58%
$565.63
price up icon 0.69%
$3.99
price up icon 5.28%
$285.31
price up icon 0.67%
$71.31
price up icon 2.56%
Capitalizzazione:     |  Volume (24 ore):